AG真人官方

STOCK TITAN
  1. Home
  2. News
  3. AMGN
  4. BetterInvesting鈩� Magazine Update on The Walt Disney Co. (NYSE: DIS)

BetterInvesting鈩� Magazine Update on The Walt Disney Co. (NYSE: DIS)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
BetterInvesting Magazine has announced The Walt Disney Co. (NYSE: DIS) as its "Stock to Study" for the August 2025 issue, replacing the previously selected Stride Inc. The decision comes as investors question whether Disney's stock is overvalued or presents a buying opportunity. The magazine will provide comprehensive fundamental data analysis, including sales, earnings, pre-tax profit, and return on equity metrics through the National Association of Investors Corp. The August 2025 issue will also feature a fundamental review of Amgen Inc. (NASDAQ: AMGN), which the Editorial Advisory and Securities Review Committee considers potentially undervalued. The committee, comprising six CFA charterholders and chaired by editor Doron P. Levin, emphasizes that these securities are presented for educational purposes only and should not be considered as endorsed investment recommendations.
La rivista BetterInvesting Magazine ha annunciato che The Walt Disney Co. (NYSE: DIS) sar脿 la "Stock to Study" per il numero di agosto 2025, sostituendo la precedente scelta Stride Inc. Questa decisione arriva in un momento in cui gli investitori si interrogano se il titolo Disney sia sopravvalutato o rappresenti un'opportunit脿 di acquisto. La rivista fornir脿 un'analisi dettagliata dei dati fondamentali, inclusi vendite, utili, profitto ante imposte e rendimento del capitale proprio, attraverso la National Association of Investors Corp. Il numero di agosto 2025 presenter脿 anche una revisione fondamentale di Amgen Inc. (NASDAQ: AMGN), che il Comitato Editoriale Consultivo e di Revisione dei Titoli ritiene potenzialmente sottovalutata. Il comitato, composto da sei titolari della certificazione CFA e presieduto dall'editore Doron P. Levin, sottolinea che questi titoli sono presentati esclusivamente a scopo educativo e non devono essere considerati raccomandazioni di investimento approvate.
La revista BetterInvesting Magazine ha anunciado que The Walt Disney Co. (NYSE: DIS) ser谩 la "Stock to Study" para la edici贸n de agosto de 2025, reemplazando a Stride Inc., que hab铆a sido seleccionada previamente. Esta decisi贸n surge en un momento en que los inversores se preguntan si las acciones de Disney est谩n sobrevaloradas o representan una oportunidad de compra. La revista proporcionar谩 un an谩lisis completo de datos fundamentales, incluyendo ventas, ganancias, beneficio antes de impuestos y retorno sobre el capital, a trav茅s de la National Association of Investors Corp. La edici贸n de agosto de 2025 tambi茅n incluir谩 una revisi贸n fundamental de Amgen Inc. (NASDAQ: AMGN), que el Comit茅 Editorial Asesor y de Revisi贸n de Valores considera potencialmente infravalorada. El comit茅, compuesto por seis titulares de la certificaci贸n CFA y presidido por el editor Doron P. Levin, enfatiza que estos valores se presentan 煤nicamente con fines educativos y no deben considerarse recomendaciones de inversi贸n aprobadas.
BetterInvesting 毵り卑歆勳潃 2025雲� 8鞗旐樃鞚� "Stock to Study"搿� The Walt Disney Co. (NYSE: DIS)毳� 靹犾爼頄堧嫟瓿� 氚滍憸頄堨溂氅�, 鞚挫爠鞐� 靹犾爼霅橃棃雿� Stride Inc.毳� 雽�觳错暕雼堧嫟. 鞚措姅 韴瀽鞛愲摛鞚� 霐旍雼� 欤检嫕鞚� 瓿茧寑韽夑皜霅橃棃電旍 鞎勲媹氅� 毵れ垬 旮绊殞鞚胳毳� 瓿犽頃橂姅 鞁滌爯鞐� 鞚措（鞏挫 瓴办爼鞛呺媹雼�. 毵り卑歆勳潃 National Association of Investors Corp.毳� 韱淀暣 毵れ稖, 靾橃澋, 靹胳爠 鞚挫澋, 鞛愱赴鞛愲掣鞚挫澋毳� 霌� 韽磩鞝侅澑 旮半掣 雿办澊韯� 攵勳劃鞚� 鞝滉车頃� 鞓堨爼鞛呺媹雼�. 2025雲� 8鞗旐樃鞐愲姅 鞛犾灛鞝侅溂搿� 鞝�韽夑皜霅橃棃雼り碃 韼胳 鞛愲 氚� 歃濌秾 瓴�韱� 鞙勳洂須岅皜 韺愲嫧頃� Amgen Inc. (NASDAQ: AMGN)鞐� 雽�頃� 旮半掣鞝� 瓴�韱犽弰 韽暔霅╇媹雼�. 鞚� 鞙勳洂須岆姅 6氇呾潣 CFA 鞛愱博 氤挫湢鞛愲 甑劚霅橃棃鞙茧┌ 韼胳鞛� Doron P. Levin鞚� 鞙勳洂鞛レ潉 毵￡碃 鞛堨溂氅�, 鞚� 歃濌秾霌れ潃 甑愳湣 氇╈爜鞙茧毵� 鞝滉车霅橂┌ 鞀轨澑霅� 韴瀽 甓岅碃搿� 臧勳＜霅橃柎靹滊姅 鞎� 霅滊嫟瓿� 臧曥“頃╇媹雼�.
Le magazine BetterInvesting a annonc茅 que The Walt Disney Co. (NYSE : DIS) sera la "Stock to Study" pour le num茅ro d'ao没t 2025, rempla莽ant Stride Inc. pr茅c茅demment s茅lectionn茅. Cette d茅cision intervient alors que les investisseurs s'interrogent sur une possible sur茅valuation de l'action Disney ou sur une opportunit茅 d'achat. Le magazine fournira une analyse compl猫te des donn茅es fondamentales, incluant les ventes, les b茅n茅fices, le r茅sultat avant imp么ts et le rendement des capitaux propres, via la National Association of Investors Corp. Le num茅ro d'ao没t 2025 pr茅sentera 茅galement une revue fondamentale d'Amgen Inc. (NASDAQ : AMGN), que le Comit茅 consultatif 茅ditorial et de r茅vision des titres consid猫re comme potentiellement sous-茅valu茅e. Ce comit茅, compos茅 de six titulaires du CFA et pr茅sid茅 par le r茅dacteur en chef Doron P. Levin, souligne que ces titres sont pr茅sent茅s 脿 des fins 茅ducatives uniquement et ne doivent pas 锚tre consid茅r茅s comme des recommandations d'investissement approuv茅es.
Das BetterInvesting Magazine hat The Walt Disney Co. (NYSE: DIS) als "Stock to Study" f眉r die Ausgabe August 2025 bekannt gegeben und ersetzt damit die zuvor ausgew盲hlte Stride Inc. Die Entscheidung f盲llt zu einem Zeitpunkt, an dem Investoren sich fragen, ob die Disney-Aktie 眉berbewertet ist oder eine Kaufgelegenheit darstellt. Das Magazin wird eine umfassende Fundamentaldatenanalyse bereitstellen, einschlie脽lich Umsatz, Gewinn, Vorsteuerergebnis und Eigenkapitalrendite, 眉ber die National Association of Investors Corp. Die August-Ausgabe 2025 wird zudem eine fundamentale 脺berpr眉fung von Amgen Inc. (NASDAQ: AMGN) enthalten, die vom Editorial Advisory und Securities Review Committee als potenziell unterbewertet angesehen wird. Das Komitee, bestehend aus sechs CFA-Charterinhabern und unter dem Vorsitz des Herausgebers Doron P. Levin, betont, dass diese Wertpapiere ausschlie脽lich zu Bildungszwecken pr盲sentiert werden und nicht als empfohlene Investitionen gelten sollten.
Positive
  • Selected as BetterInvesting Magazine's Stock to Study for August 2025
  • Comprehensive fundamental analysis will be provided through NAIC platform
Negative
  • None.

TROY, Mich., June 5, 2025 /PRNewswire/ -- Based on recent updated information, the Securities Review Committee of聽BetterInvesting Magazine has revised its previous decision pertaining to Stride Inc.'s announced selection as the "Stock to Study" for the August 2025 issue. The Walt Disney has been chosen instead as the "Stock to Study" for August.

The Walt Disney Co.'s recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine consider 听(狈驰厂贰:DIS) as worthy of further study and has named the company its "Stock to Study" for the August 2025 issue for investors' informational and educational use.

The fundamental data is eye-opening; investors can view Disney's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at: .

A full report on Disney will appear in the August 2025 issue of BetterInvesting Magazine.聽

The same issue of BetterInvesting Magazine will also include a fundamental review of Amgen Inc.聽 (AMGN: NASDAQ), which the independent Editorial Advisory and Securities Review Committee believes is worthy of further study from an undervalued perspective.聽

Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

Doron P. Levin, an editor of the magazine, serves as the committee's chairperson.

Securities mentioned are for study and presented for educational purposes only. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

About BetterInvesting:

BetterInvesting鈩�, a national聽501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors鈩� (NAIC庐), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit

Follow us on ,听补苍诲 .

Contact: 877-275-6242

Cision View original content:

SOURCE NAIC-BetterInvesting

FAQ

Why was Disney (DIS) chosen as BetterInvesting Magazine's Stock to Study for August 2025?

Disney was chosen due to investor interest in determining whether the stock is currently overvalued or presents a buying opportunity, replacing the previously selected Stride Inc.

What fundamental data will be analyzed in BetterInvesting's Disney (DIS) study?

The analysis will cover Disney's sales, earnings, pre-tax profit, return on equity, and other fundamental metrics through the National Association of Investors Corp. platform.

Who are the members of BetterInvesting Magazine's Editorial Advisory and Securities Review Committee?

The committee consists of six CFA charterholders: Daniel J. Boyle, Marisa Bradbury, Philip Keating, Walter J. Kirchberger, Anne Nichols, and Dan Rutter, with editor Doron P. Levin serving as chairperson.

What other company will be featured alongside Disney in the August 2025 issue?

Amgen Inc. (NASDAQ: AMGN) will also be featured in the issue with a fundamental review, as the committee believes it may be undervalued.
Stock AMGN logo
Amgen Inc

NASDAQ:AMGN

AMGN Rankings

#89 Ranked by Market Cap
#1029 Ranked by Dividends

AMGN Latest News

Jun 30, 2025
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER
Jun 23, 2025
RESULTS FROM AMGEN'S PHASE 2 OBESITY STUDY OF MONTHLY MARITIDE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS
Jun 18, 2025
AMGEN'S PHASE 2 MARITIDE DATA TO BE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS
Jun 13, 2025
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY
Jun 5, 2025
AMGEN TO PRESENT AT GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

AMGN Stock Data

150.75B
536.49M
0.22%
82.06%
3.01%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
United States
THOUSAND OAKS

Related Articles

Continue reading with these related stories

View All Latest News